|
Which vaccine trial is this? I am looking into one at UAMS with Linda Hutchins. Here is some info from the letter... I will make a new post with the whole letter for those who are interested.
"Dr. Laura Hutchins, director of the Division of Hematology and Oncology here at UAMS, is principal investigator for the clinical trial. The first phase of the clinical trial will last four to six months. It will involve women with metastatic cancer only, who have relapsed after going into remission. Women participating in the study will receive five doses of the vaccine at the Cancer Institute's Medical Oncology Clinic. They will be immunized once a week for the first three weeks and again during the seventh and 19th weeks. The first phase is to monitor any side effects of the vaccine. "
__________________
Jan04: Bilateral Mastectomy at age 28
Initial DX: Left Breast: IDC 2cm, Grade 3, HER2+3, 0 Nodes +, ER/PR-. Right Breast: Extensive DCIS ER-/PR+; Stage 1-2a
Feb04-Apr04: 4 AC, dose dense
Aug 04: 4 Taxotere
Dec 05: Bone and Liver METS; Stage 4. Carboplatin/Taxol/Herceptin. DX with Li-Fraumeni Syndrome
Apr 06: NED, maintenance Herceptin
Apr 07: CA1503=14; masses in liver; Xeloda/Tykerb
Nov 07: NED, Tykerb maintenance
Sept 08: Liver mets again, on Tykerb/Xeloda again, CA=19 and 27
Nov 08: Progression, Tykerb/Gemzar, CA=25
Dec 08: Progression, Herceptin/Navelbine, CA=40, 57, and 130
Jan 09: Progression in bone, recession in liver, Herceptin/Carbo/Abraxane CA=135
June 09: CA27/29=24, chemo break
Sept 09: Progression, CA=24, waiting on clinical trial (4 weeks no treatment)
Nov 09: now have brain mets, trial "on hold", getting 14 WBR treatments starting 11/2/09
Dec 09: possible start on p53 trial
|